Novoeight
Payments companies reported to CMS as associated with Novoeight. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Novoeight, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Novoeight
These are the largest totals companies reported as associated with Novoeight. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $17,618.61 |
| Steven Pipe | Ann Arbor, MI | Pediatric Hematology-Oncology | $1,190.00 |
| Neha Vaghasia | Los Angeles, CA | Pediatrics | $616.41 |
| Kenji Morimoto | Los Angeles, CA | Pediatric Hematology-Oncology | $341.77 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $297.95 |
| Moran Gotesman | Torrance, CA | Pediatric Hematology-Oncology | $235.19 |
| Eduard Panosyan | Torrance, CA | Pediatrics | $138.57 |
| Nina Hwang | Orange, CA | Pediatrics | $128.61 |
| Vanessa Salinas-Luna | Orange, CA | Pediatric Hematology-Oncology | $128.60 |
| Christopher Chan | Los Angeles, CA | Family | $126.74 |
Prescribed Novoeight?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.